Elisabeth Seja

1.2k citations
7 papers · 971 indexed · h-index 7
Topics
Immunotherapy and Immune Responses (7 papers)T-cell and B-cell Immunology (5 papers)CAR-T cell therapy research (3 papers)
Partner nations
United StatesPoland

In The Last Decade

Elisabeth Seja

7 papers receiving 952 citations

Peers

Elisabeth Seja
Comparison fields: 5 of 53
  • Immunology 737
  • Oncology 687
  • Molecular Biology 193
  • Epidemiology 107
  • Hepatology 94
Replace Yoon Lee with:
Yoon Lee South Korea
Linghua Zheng United States
Elizabeth Seja United States
Shi-Ping Chen China
Angela D. Pardee United States
Cathy Biota France
Zhengguang Wang China
Jean-Claude D. Schwartz United States
Stergios Moschos United States
Elisabeth Sievers Germany
Elisabeth Seja relative to Yoon Lee South Korea Yoon Lee's profile →
Citations per field
00.5×2.7×
Yoon Lee · 1×
Citations per year

Countries citing papers authored by Elisabeth Seja

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Seja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Seja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Seja more than expected).

Fields of papers citing papers by Elisabeth Seja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Seja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Seja. The network helps show where Elisabeth Seja may publish in the future.

Co-authorship network of co-authors of Elisabeth Seja

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Seja. A scholar is included among the top collaborators of Elisabeth Seja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Seja. Elisabeth Seja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 64
2 14
3 199
4 29
5 439
6 89
7
T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.
137

About Elisabeth Seja

Elisabeth Seja is a scholar working on Immunology, Oncology and Ophthalmology, having authored 7 papers that have together received 971 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (5 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Immunology (737 citations), Oncology (687 citations) and Hepatology (94 citations). Elisabeth Seja has collaborated with scholars based in United States and Poland. Frequent co-authors include John A. Glaspy, Antoni Ribas, Jesús Gómez-Navarro, James S. Economou, Begoña Comı́n-Anduix, Luis H. Camacho, C. A. Bulanhagui, James M. Reuben, Dmitri Pavlov and Robert Millham. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and American Journal of Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026